-
1
-
-
6044266281
-
Somatostatin and other peptide receptors as tools for tumor diagnosis and treatment
-
Reubi JC. Somatostatin and other peptide receptors as tools for tumor diagnosis and treatment. Neuroendocrinology 2004; 80 Suppl 1: 51-56.
-
(2004)
Neuroendocrinology
, vol.80
, Issue.SUPPL 1
, pp. 51-56
-
-
Reubi, J.C.1
-
2
-
-
69749113601
-
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification
-
Kloppel G, Couvelard A, Perren A, Komminoth P, McNicol AM, Nilsson O, Scarpa A, Scoazec JY, Wiedenmann B, Papotti M, Rindi G and Plockinger U. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009; 90: 162-166.
-
(2009)
Neuroendocrinology
, vol.90
, pp. 162-166
-
-
Kloppel, G.1
Couvelard, A.2
Perren, A.3
Komminoth, P.4
McNicol, A.M.5
Nilsson, O.6
Scarpa, A.7
Scoazec, J.Y.8
Wiedenmann, B.9
Papotti, M.10
Rindi, G.11
Plockinger, U.12
-
3
-
-
43749091955
-
Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0 Tyr3] octreotate: toxicity, efficacy, and survival
-
Kwekkeboom DJ, de Herder WW, Kam BL, van Eijck CH, van Essen M, Kooij PP, Feelders RA, van Aken MO and Krenning EP. Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3] octreotate: toxicity, efficacy, and survival. J Clin Oncol 2008; 26: 2124-2130.
-
(2008)
J Clin Oncol
, vol.26
, pp. 2124-2130
-
-
Kwekkeboom, D.J.1
de Herder, W.W.2
Kam, B.L.3
van Eijck, C.H.4
van Essen, M.5
Kooij, P.P.6
Feelders, R.A.7
van Aken, M.O.8
Krenning, E.P.9
-
4
-
-
34547877609
-
Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view
-
Prasad V, Fetscher S and Baum RP. Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view. J Pharm Pharm Sci 2007; 10: 321s-337s.
-
(2007)
J Pharm Pharm Sci
, vol.10
-
-
Prasad, V.1
Fetscher, S.2
Baum, R.P.3
-
5
-
-
57249095880
-
Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT
-
Miederer M, Seidl S, Buck A, Scheidhauer K, Wester HJ, Schwaiger M and Perren A. Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT. Eur J Nucl Med Mol Imaging 2009; 36: 48-52.
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, pp. 48-52
-
-
Miederer, M.1
Seidl, S.2
Buck, A.3
Scheidhauer, K.4
Wester, H.J.5
Schwaiger, M.6
Perren, A.7
-
6
-
-
57349142534
-
Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1
-
Fischer T, Doll C, Jacobs S, Kolodziej A, Stumm R and Schulz S. Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1. J Clin Endocrinol Metab 2008; 93: 4519-4524.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 4519-4524
-
-
Fischer, T.1
Doll, C.2
Jacobs, S.3
Kolodziej, A.4
Stumm, R.5
Schulz, S.6
-
7
-
-
81355123315
-
Reassessment of sst(5) Somatostatin Receptor Expression in Normal and Neoplastic Human Tissues Using the Novel Rabbit Monoclonal Antibody UMB-4
-
Lupp A, Hunder A, Petrich A, Nagel F, Doll C and Schulz S. Reassessment of sst(5) Somatostatin Receptor Expression in Normal and Neoplastic Human Tissues Using the Novel Rabbit Monoclonal Antibody UMB-4. Neuroendocrinology 2011; 94(3): 255-64.
-
(2011)
Neuroendocrinology
, vol.94
, Issue.3
, pp. 255-264
-
-
Lupp, A.1
Hunder, A.2
Petrich, A.3
Nagel, F.4
Doll, C.5
Schulz, S.6
-
8
-
-
84860734631
-
Monoclonal Antibodies against the Human Somatostatin Receptor Subtypes 1-5: Development and Immunohistochemical Application in Neuroendocrine Tumors
-
Schmid HA, Lambertini C, van Vugt HH, Barzaghi-Rinaudo P, Schafer J, Hillenbrand R, Sailer AW, Kaufmann M and Nuciforo P. Monoclonal Antibodies against the Human Somatostatin Receptor Subtypes 1-5: Development and Immunohistochemical Application in Neuroendocrine Tumors. Neuroendocrinology 2012; 95(3): 232-47
-
(2012)
Neuroendocrinology
, vol.95
, Issue.3
, pp. 232-247
-
-
Schmid, H.A.1
Lambertini, C.2
van Vugt, H.H.3
Barzaghi-Rinaudo, P.4
Schafer, J.5
Hillenbrand, R.6
Sailer, A.W.7
Kaufmann, M.8
Nuciforo, P.9
-
11
-
-
42749095844
-
Preclinical evidences suggest new treatment options for endocrine disorders: Pasireotide (SOM230) and Everolimus (RAD001)
-
Schmid HA. Preclinical evidences suggest new treatment options for endocrine disorders: Pasireotide (SOM230) and Everolimus (RAD001). Ann Endocrinol (Paris) 2008; 69: 162-163.
-
(2008)
Ann Endocrinol (Paris)
, vol.69
, pp. 162-163
-
-
Schmid, H.A.1
-
12
-
-
43549111835
-
Pasireotide (SOM230): development, mechanism of action and potential applications
-
Schmid HA. Pasireotide (SOM230): development, mechanism of action and potential applications. Mol Cell Endocrinol 2008; 286: 69-74.
-
(2008)
Mol Cell Endocrinol
, vol.286
, pp. 69-74
-
-
Schmid, H.A.1
-
13
-
-
83455211387
-
Effects of somatostatin analogs on glucose homeostasis in rats
-
Schmid HA and Brueggen J. Effects of somatostatin analogs on glucose homeostasis in rats. J Endocrinol 2012 Jan; 212: 49-60.
-
(2012)
J Endocrinol
, vol.212
, pp. 49-60
-
-
Schmid, H.A.1
Brueggen, J.2
-
14
-
-
80455174041
-
Molecular imaging with Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours
-
Kaemmerer D, Peter L, Lupp A, Schulz S, Sanger J, Prasad V, Kulkarni H, Haugvik SP, Hommann M and Baum RP. Molecular imaging with Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2011; 38: 1659-1668.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, pp. 1659-1668
-
-
Kaemmerer, D.1
Peter, L.2
Lupp, A.3
Schulz, S.4
Sanger, J.5
Prasad, V.6
Kulkarni, H.7
Haugvik, S.P.8
Hommann, M.9
Baum, R.P.10
-
15
-
-
76049119700
-
Immunohistochemical expression of somatostatin receptors in digestive endocrine tumours
-
Zamora V, Cabanne A, Salanova R, Bestani C, Domenichini E, Marmissolle F, Giacomi N, O'Connor J, Mendez G and Roca E. Immunohistochemical expression of somatostatin receptors in digestive endocrine tumours. Dig Liver Dis 2010; 42: 220-225.
-
(2010)
Dig Liver Dis
, vol.42
, pp. 220-225
-
-
Zamora, V.1
Cabanne, A.2
Salanova, R.3
Bestani, C.4
Domenichini, E.5
Marmissolle, F.6
Giacomi, N.7
O'Connor, J.8
Mendez, G.9
Roca, E.10
-
16
-
-
40849118727
-
Immunohistochemical detection of somatostatin receptor (SSTR) subtypes 2A and 5 in pituitary adenoma from acromegalic patients: good correlation with preoperative response to octreotide
-
Takei M, Suzuki M, Kajiya H, Ishii Y, Tahara S, Miyakoshi T, Egashira N, Takekoshi S, Sanno N, Teramoto A and Osamura RY. Immunohistochemical detection of somatostatin receptor (SSTR) subtypes 2A and 5 in pituitary adenoma from acromegalic patients: good correlation with preoperative response to octreotide. Endocr Pathol 2007; 18: 208-216.
-
(2007)
Endocr Pathol
, vol.18
, pp. 208-216
-
-
Takei, M.1
Suzuki, M.2
Kajiya, H.3
Ishii, Y.4
Tahara, S.5
Miyakoshi, T.6
Egashira, N.7
Takekoshi, S.8
Sanno, N.9
Teramoto, A.10
Osamura, R.Y.11
-
17
-
-
0036135375
-
Identification of somatostatin receptor subtypes 1 2A 3 and 5 in neuroendocrine tumours with subtype specific antibodies
-
Kulaksiz H, Eissele R, Rossler D, Schulz S, Hollt V, Cetin Y and Arnold R. Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies. Gut 2002; 50: 52-60.
-
(2002)
Gut
, vol.50
, pp. 52-60
-
-
Kulaksiz, H.1
Eissele, R.2
Rossler, D.3
Schulz, S.4
Hollt, V.5
Cetin, Y.6
Arnold, R.7
-
18
-
-
0036271475
-
Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis
-
Papotti M, Bongiovanni M, Volante M, Allia E, Landolfi S, Helboe L, Schindler M, Cole SL and Bussolati G. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Arch 2002; 440: 461-475.
-
(2002)
Virchows Arch
, vol.440
, pp. 461-475
-
-
Papotti, M.1
Bongiovanni, M.2
Volante, M.3
Allia, E.4
Landolfi, S.5
Helboe, L.6
Schindler, M.7
Cole, S.L.8
Bussolati, G.9
-
19
-
-
0035726431
-
Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid
-
Papotti M, Kumar U, Volante M, Pecchioni C and Patel YC. Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid. Clin Endocrinol (Oxf) 2001; 54: 641-649.
-
(2001)
Clin Endocrinol (Oxf)
, vol.54
, pp. 641-649
-
-
Papotti, M.1
Kumar, U.2
Volante, M.3
Pecchioni, C.4
Patel, Y.C.5
-
20
-
-
0042854927
-
Peptide receptors as molecular targets for cancer diagnosis and therapy
-
Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 2003; 24: 389-427.
-
(2003)
Endocr Rev
, vol.24
, pp. 389-427
-
-
Reubi, J.C.1
-
21
-
-
33744978582
-
Preclinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects
-
Hofland LJ, van der Hoek J, Feelders R, van der Lely AJ, de Herder W and Lamberts SW. Preclinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects. J Endocrinol Invest 2005; 28: 36-42.
-
(2005)
J Endocrinol Invest
, vol.28
, pp. 36-42
-
-
Hofland, L.J.1
van der Hoek, J.2
Feelders, R.3
van der Lely, A.J.4
de Herder, W.5
Lamberts, S.W.6
|